Citation: Jm. Zgombick et Ta. Branchek, NATIVE 5-HT1B RECEPTORS EXPRESSED IN OH CELLS DISPLAY DUAL COUPLING TO ELEVATION OF INTRACELLULAR CALCIUM CONCENTRATIONS AND INHIBITION OF ADENYLATE-CYCLASE, Naunyn-Schmiedeberg's archives of pharmacology, 358(5), 1998, pp. 503-508
Citation: N. Adham et al., FUNCTIONAL-CHARACTERIZATION OF THE RECOMBINANT HUMAN 5-HYDROXYTRYPTAMINE(7(A)) RECEPTOR ISOFORM COUPLED TO ADENYLATE-CYCLASE STIMULATION, The Journal of pharmacology and experimental therapeutics, 287(2), 1998, pp. 508-514
Authors:
ZGOMBICK JM
BARD JA
KUCHAREWICZ SA
URQUHART DA
WEINSHANK RL
BRANCHEK TA
Citation: Jm. Zgombick et al., MOLECULAR-CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF GUINEA-PIG 5-HT1B AND 5-HT1D RECEPTORS, Neuropharmacology, 36(4-5), 1997, pp. 513-524
Authors:
ADHAM N
BARD JA
ZGOMBICK JM
DURKIN MM
KUCHAREWICZ S
WEINSHANK RL
BRANCHEK TA
Citation: N. Adham et al., CLONING AND CHARACTERIZATION OF THE GUINEA-PIG 5-HT1F RECEPTOR SUBTYPE - A COMPARISON OF THE PHARMACOLOGICAL PROFILE TO THE HUMAN SPECIES HOMOLOG, Neuropharmacology, 36(4-5), 1997, pp. 569-576
Authors:
PHEBUS LA
JOHNSON KW
ZGOMBICK JM
GILBERT PJ
VANBELLE K
MANCUSO V
NELSON DLG
CALLIGARO DO
KIEFER AD
BRANCHEK TA
FLAUGH ME
Citation: La. Phebus et al., CHARACTERIZATION OF LY344864 AS A PHARMACOLOGICAL TOOL TO STUDY 5-HT1F RECEPTORS - BINDING AFFINITIES, BRAIN PENETRATION AND ACTIVITY IN THE NEUROGENIC DURAL INFLAMMATION MODEL OF MIGRAINE, Life sciences, 61(21), 1997, pp. 2117-2126
Authors:
ZGOMBICK JM
SCHECHTER LE
ADHAM N
KUCHAREWICZ SA
WEINSHANK RL
BRANCHEK TA
Citation: Jm. Zgombick et al., PHARMACOLOGICAL CHARACTERIZATIONS OF RECOMBINANT HUMAN 5-HT1D-ALPHA AND 5-HT1D-BETA RECEPTOR SUBTYPES COUPLED TO ADENYLATE-CYCLASE INHIBITION IN CLONAL CELL-LINES - APPARENT DIFFERENCES IN DRUG INTRINSIC EFFICACIES BETWEEN HUMAN 5-HT1D SUBTYPES, Naunyn-Schmiedeberg's archives of pharmacology, 354(3), 1996, pp. 226-236
Authors:
BARD JA
KUCHAREWICZ SA
ZGOMBICK JM
WEINSHANK RL
BRANCHEK TA
COHEN ML
Citation: Ja. Bard et al., DIFFERENCES IN LIGAND-BINDING PROFILES BETWEEN CLONED RABBIT AND HUMAN 5-HT1D-ALPHA AND 5-HT1D-BETA RECEPTORS - KETANSERIN AND METHIOTHEPINDISTINGUISH RABBIT 5-HT1D RECEPTOR SUBTYPES, Naunyn-Schmiedeberg's archives of pharmacology, 354(3), 1996, pp. 237-244
Authors:
CUSHING DJ
ZGOMBICK JM
NELSON DL
COHEN ML
Citation: Dj. Cushing et al., LY215840, A HIGH-AFFINITY 5-HT7 RECEPTOR-LIGAND, BLOCKS SEROTONIN-INDUCED RELAXATION IN CANINE CORONARY-ARTERY, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1560-1566
Authors:
ZGOMBICK JM
SCHECHTER LE
KUCHAREWICZ SA
WEINSHANK RL
BRANCHEK TA
Citation: Jm. Zgombick et al., KETANSERIN AND RITANSERIN DISCRIMINATE BETWEEN RECOMBINANT HUMAN 5-HT1D-ALPHA AND 5-HT1D-BETA RECEPTOR SUBTYPES, European journal of pharmacology. Molecular pharmacology section, 291(1), 1995, pp. 9-15
Authors:
ZGOMBICK JM
BORDEN LA
COCHRAN TL
KUCHAREWICZ SA
WEINSHANK RL
BRANCHEK TA
Citation: Jm. Zgombick et al., DUAL COUPLING OF CLONED HUMAN 5-HYDROXYTRYPTAMINE1D-ALPHA AND 5-HYDROXYTRYPTAMINE1D-BETA RECEPTORS STABLY EXPRESSED IN MURINE FIBROBLASTS -INHIBITION OF ADENYLATE-CYCLASE AND ELEVATION OF INTRACELLULAR CALCIUM CONCENTRATIONS VIA PERTUSSIS-TOXIN-SENSITIVE G-PROTEIN(S), Molecular pharmacology, 44(3), 1993, pp. 575-582
Authors:
ZGOMBICK JM
WEINSHANK RL
MACCHI M
SCHECHTER LE
BRANCHEK TA
HARTIG PR
Citation: Jm. Zgombick et al., EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF A CANINE 5-HYDROXYTRYPTAMINE1D RECEPTOR SUBTYPE, Molecular pharmacology, 40(6), 1991, pp. 1036-1042